Effects of combined acetylcholinesterase inhibition and serotonergic receptor blockade on age-associated memory impairments in rats.
We recently reported that post-training administration of serotonergic receptor antagonists attenuated the inhibitory-avoidance memory deficits normally exhibited by aged rats. In the present study, we determined whether a subeffective dose of the serotonergic type-2 receptor antagonist, ketanserin, would augment the facilitative effects produced by the acetylcholinesterase inhibitor, physostigmine, on memory in aged rats using the same task. The drugs were injected intraperitoneally alone, or in combination, immediately following training. Retention testing occurred 24 hours following training. A dose-dependent enhancement of memory was demonstrated as a result of the two treatment conditions (physostigmine 0.01-10.0 micrograms/kg, ketanserin 1.0 mg/kg + physostigmine 0.001-0.01 micrograms/kg). The facilitation of memory produced by the combined treatment was observed at doses well below those required to produce a similar effect when each drug was administered alone. The results provide additional evidence for an interaction between the cholinergic and serotonergic neurotransmitter systems in learning and memory, and may have important implications in the treatment of age-related memory impairments.
Normile
H J
HJ
Wayne State University, Department of Psychiatry, Detroit 48207.
Altman
H J
HJ
D000375:Aging / Q000523:psychology*; D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D007650:Ketanserin / Q000627:therapeutic use; D008297:Male; D008569:Memory Disorders / Q000188:drug therapy* / Q000523:psychology; D010830:Physostigmine / Q000627:therapeutic use; D051381:Rats; D017207:Rats, Sprague-Dawley; D012702:Serotonin Antagonists
D002800:Cholinesterase Inhibitors; D012702:Serotonin Antagonists; D007650:Ketanserin; D010830:Physostigmine